IES84572Y1 - Cosmetic compositions containing lingonberry (vaccinium vitis idea) extracts - Google Patents
Cosmetic compositions containing lingonberry (vaccinium vitis idea) extractsInfo
- Publication number
- IES84572Y1 IES84572Y1 IE2006/0449A IE20060449A IES84572Y1 IE S84572 Y1 IES84572 Y1 IE S84572Y1 IE 2006/0449 A IE2006/0449 A IE 2006/0449A IE 20060449 A IE20060449 A IE 20060449A IE S84572 Y1 IES84572 Y1 IE S84572Y1
- Authority
- IE
- Ireland
- Prior art keywords
- skin
- lingonberry
- extract
- cranberry
- fruit
- Prior art date
Links
Description
COSMETIC COMPOSITIONS CONTAINING LINGONBERRY
(VACCINIUM VITIS IDEA) EXTRACTS
Field of the Invention
The present invention relates to topical compositions for application to human skin
and to their use in improving the condition and appearance of skin.
Background Art
As the skin is the outermost aspect of our bodies it is subject to deterioration through
environmental abuse (wind, air conditioning, central heating) or through the normal
aging process on non-sun exposed areas (chronological aging) which may be
accelerated by exposure of skin to sun (photoaging). As a result of this the consumer
demands highly effective products to prevent the aging process.
In this respect consumers are increasingly seeking “anti-aging" cosmetic products
which treat or delay the visible signs of aging skin such as wrinkles, lines. sagging,
hyperpigmentation and age spots in addition to cosmetic products improving the
appearance and condition of dry and flaky skin and to soothe irritated and itchy skin.
Skin care cosmetic and dermatological compositions for improving the condition and
appearance of skin comprising botanical extracts are well known in the art.
Cranberries are well known for their health promoting activities. Arctic berry seed oils.
including cranberry (Vaccinium oxycoccus) oil and lingonberry (Vaccinium vitis idea)
seed oil. are commonly found in cosmetic products. Arctic berry seed oils contain
predominantly fatty acids such as linoleic and alpha—|inolenic acids.
Cranberry seed oil is known in the art For use in cosmetic compositions. international
Publication Number WO 00/72862 discloses isolated cranberry seed oil and
components thereof in a form suitable for use as a foodstuff, dietary supplement, or a
pharmaceutical composition. The isolated cranberry seed oil or compositions
comprising one or a combination of components derived from the cranberry seed oil
can be used as antioxidizing agents. for example.
Other cranberry extracts including cranberry juice and cranberry fruit extracts are
known for use in cosmetic compositions. Japanese Patent no. JP2002275080 describes
a skin care preparation comprising pressed juice of the cranberry fruit and/or the
extract from the cranberry fruit together with one or more kinds of medicinally
effective compounds. The skin care preparation has inhibitory effects on melanin
formation.
JP2002003389 describes a cosmetic which acts as a radical scavenger having
excellent radical scavenging properties. The composition comprises a pressed and
filtered substance and/or extract of a cranberry fruit consisting essentially of an
anthocyanine polymer.
Aqueous lingonberry extracts are different from the seed oil or cranberry extracts in
their content of flavonoids and phenolic acids.
There is therefore a need for alternative effective cosmetic compositions for topical
application to skin for treating and/or delaying the visible signs of aging and
photodamaged skin such as wrinkles, lines, sagging, hyperpigmentation, skin dryness
and age spots.
lt is therefore an object ofthe invention to provide a cosmetic composition for treating
and or preventing normal skin conditions due to chronological aging or photoaging,
such as wrinkles, lines, sagging, hyperpigmentation and age spots. and/or of dry, flaky,
itchyr irritated skin.
Summai_'y of the Invention
Accordingly, the invention provides the use ofa therapeutically effective amount of
an aqueous extract of a combination of lingonberry (Vaccinium vitis idea) fruit and
leaf extract and/or derivatives thereof, in the manufacture of a cosmetic composition
for treating skin conditions. The cosmetic composition is suitable for use in conditions
selected from the group consisting of wrinkling, sagging, photodamaged skin, dry
skin, flaky skin, irritated skin, itchy skin and age spots.
f\_)
l\_)
(ft
In a preferred embodiment, about 50% by weight of the lingonberry (Swedish
cranberry) extract, and/or derivatives thereof, is present as the leaf extract and the
other 50% as the fruit extract. Preferably at least 50% by weight of the extract is
present as leaf extract. It has been surprisingly found that effective treatment and
prevention of skin conditions clue to chronological aging or photoaging, such as
wrinkles, lines, sagging, hyperpigmentation and age spots. and/or of dry, flaky, itchy.
irritated skin may be obtained through the application of cosmetic compositions to the
skin which comprise a specific synergistic combination of lingonberry (Swedish
cranberry) fruit and leaf extract or derivatives thereof.
The cosmetic composition may comprise between 0.0001"/o to 50% by weight of
lingonberry (Swedish cranberry) extract, preferably between 0.01% to l % by weight
of lingonberry (Swedish cranberry) extract, most preferably between 0.1% to 5% by
weight of lingonberry (Swedish cranberry) extract.
Such compositions are particularly useful for topical application to human skin for
cosmetically treating and/or preventing skin conditions selected from the group
consisting of wrinkling, sagging, photo—damaged skin, dry skin, flaky skin, irritated
skin, itchy skin and age spots. The compositions are also useful for application to the
skin as a cosmetic treatment which promotes epidermal regeneration and cellular
renewal by chelating iron, protecting against free radicals but in particular protecting
against UV irradiation, inducing epidermal differentiation and inhibiting collagenase.
Aqueous berry extracts are different from the seed oil fractions in their content of
flavonoids and phenolic acids. They contain for example kaempferol, quercetin.
myricetin, coumaric acid and ferulic acid etc. Marked differences in concentration of
the biochemicals are found in different families and genera. Cranberry is one of the
richest sources of flavonoids and in particular is rich in quercetin and myricetin. Type
A proanthocyanidins are also particularly found in cranberries whereas the B types are
found in other types of berries. Additionally compared with European cranberries
(Vaccimum oxycoccus), Swedish cranberries or Lingonberries ( Vaccinium vitis idea)
contain twice as much phenolics, higher quantities of secisolariciresinol, anthocyanins
and cyanidins together with more resveratrol.
In one embodiment. the invention provides a topical composition comprising:
(a) a therapeutically effective amount of an aqueous extract of a combination
of lingonberry (Vaccinium v1’tis idea) fruit and leaf extract together with
(b) a dermatologically acceptable carrier.
The composition according to the invention may comprise a
dermatologically/cosmetically acceptable vehicle to act as a dilutant, dispersant or
carrier for the lingonberry (Swedish cranberry) extracts. The carrier may be selected
from the group consisting of water, liquid or solid emollients. silicone oils,
emulsifiers, solvents, humectants, thickeners, powders, propellants and the like.
The carrier will usually form from 5% to 99.9%. preferably from 25% to 80% by
weight of the composition, and can, in the absence of other cosmetic adjuncts. form
the balance of the composition.
The composition may also comprise other specific skin—benefit actives such as
sunscreens, moisturising agents, skin lightening agents. The vehicle may also further
include adjuncts such as fragrances, opacifiers. preservatives, colourants, buffers and
other anti—aging ingredients.
The topical composition according to the present invention may be prepared in a
manner well known in the art for preparing skin care products. The active components
are generally incorporated in a dermatologically acceptable carrier in conventional
manner. The active components can suitably first be dissolved or dispersed in a
portion of the water or another solvent or liquid to be incorporated in the composition.
The preferred compositions are oil-in-water or water-in-oil emulsions.
The composition may be in the form of conventional skin-care products such as a
cream, gel or lotion or the like. The composition can also be in the form ofa cleanser
eg. a bath or shower gel, possibly containing a delivery system for the actives to
promote adherence to the skin during rinsing. The composition may also be a
foundation or other colouring product e.g. mascara or lipstick. Most preferably the
product is a “leave-on” topical product: a product to be applied to the skin without a
deliberate rinsing step soon after its application to the skin.
The composition may be packaged in any suitable manner such as in a jar. a bottle.
tube, roll—ball, or sachets.
The invention further provides a cosmetic method of treating/preventing skin
conditions selected from the group consisting of wrinkling, sagging, photo-damaged
skin, dry skin, flaky skin, irritated skin, itchy skin and age spots, the method
comprising applying to the skin a topical composition comprising an extract of
lingonberry (Swedish cranberry). The extract may comprise about 50 % by weight
lingonberry fruit extract and about 50% by weight lingonberry leaf extract.
The method of the present invention may be carried out one or more times daily to the
skin which requires treatment. The improvement in skin appearance will usually
become visible after 3 to 6 months, depending on skin condition, the concentration of
the active components used in the inventive method, the amount of composition used
and the frequency with which it is applied. in general, a small quantity of the
composition, for example from 0.1 to 5 ml is applied to the skin from a suitable
container or applicator and spread over and/or rubbed into the skin using the hands or
fingers or a suitable device. A rinsing step may optionally follow depending on
whether the composition is formulated as a “leave-on" or a cleansing product.
The inventive compositions and methods thus provide anti-aging benefits which result
in the promotion of smooth and supple skin with improved skin elasticity and a
reduced or delayed appearance of wrinkles and aged skin with improved skin colour.
A general improvement in the appearance, texture and condition, in particular with
respect to the radiance, clarity, and general youthful appearance of skin is achieved.
Thus the inventive methods and compositions provide a wide range of skin care
benefits.
The term “treating” as used herein includes within its scope reducing, delaying and/or
preventing the appearance of wrinkled, aged, photodamaged, dry and/or dry and
irritated skin and generally enhancing the quality of skin by improving its appearance
and texture. by preventing or reducing wrinkling and increasing flexibility. firmness.
smoothness. suppleness and elasticity of the skin. The cosmetic compositions:
methods and the uses ofthe lingonberry (Swedish cranberry) extracts according to the
invention may be useful for treating skin which is already in a wrinkled, aged,
photodamaged, dry and irritated condition or for treating youthful skin to prevent or
reduce deteriorative changes due to the normal aging but particularly the photo aging
process.
Detailed Description of the Invention
Lingonberry (Swedish cranberry - Vaccinium vitis idea) extract
Lingonberry (Vaccinium vitis idea) extract to be employed in accordance with the
present invention is present in the topical composition in an effective amount derived
from the fruit and /or from the leaf. Most preferably the combination of both extracts
will be used and most preferably a 50:50 combination ofthe leaf and fruit extract will
be used.
Lingonberry (Vuccinium vitis idea) extract comprises an aqueous extract rich in
polyphenols, particularly flavonols and flavanols, and in oligosaccharides. Both leaf
and fruit extract contain aromatic acid compounds such as hydroxybenzoic acid and
hydroxycinnamic acid, typical flavanols are epicatechin whereas typical flavonols are
quercitrin and quercetin. The leaf extract contains more flavonols compared with the
fruit such that when combined nearly equal quantities of flavanols and flavonols are
present in the lingonberry (Swedish cranberry) extracts. Nevertheless, the typical
composition ofthe combined polyphenols that could be identified is:
Compounds~
Hydroxybenzoic
Phenol
llydroxycinnamic
Flavanol
_______——_j —
Fla_\/fonol Quercetin
Due to the inherent biological variation of the polyphenols in plants these
compositions should only be taken as a typical example and their concentrations will
vary from batch to batch and year to year but approximately the same ratios between
chemical classes are anticipated.
Lingonbcrry (Vaccirzizzm vms idea) extract to be employed in accordance with the
present invention is present in the topical composition in an effective amount.
Normally the total amount ofthe active is present in an amount between 0,0001% and
50% by weight ofthe composition, More preferably the amount is from 0.01% to 10%
and most preferably from 0.1% to 5% in order to maximise benefits at a minimum
COSI.
In order that the present invention may be more readily understood. the following
examples are given. by way of illustration only.
Skin aging is a complex process controlled by a number of factors broken down into
intrinsic and extrinsic factors that include genetics, exposures to environmental stress
(UV, mechanical stress), hormonal changes or metabolism. The combined results of
these different factors are the deterioration ofthe structure ofthe skin, its function and
its appearance (Rittie et al., 2002). The influence of the environment and UV
irradiation in particular is very important in the process of skin aging (Rittie et al.,
2002). lt is now known that these effects are directly related to the flattening of the
dermal-epidermal junction, to the degradation of the fiber system of the skin, the
extracellular matrix (ECM) and to the alteration ofepidermis.
The ECM is produced by fibroblasts and keratinocytes. It is composed of
macromolecules including collagens, elastin, proteoglycans and fibronectin. Collagen
and elastin are the major components of the ECM and are contained in tissues in the
form of insoluble, rigid and stable fibers. They are tightly interwoven, organized in a
network of microfibrils that imparts solidity and mechanical resistance to connective
tissues. ECM thus acts like a physical support, but also carries out biological functions
of intercellular exchange and communication that are essential for tight connection
between the dermis and epidermis and the integrity of skin tissue.
Chronological aging or environmental stress (especially sunlight) destroys this
balance. Cellular metabolic activity decreases and the renewal of collagen fibers are
reduced. In parallel, enzymatic activities increase dramatically and result in an
excessive and anarchic degradation of collagen fibers and a loss of structure in the
ECM. The skin loses its suppleness and elasticity and becomes flaccid.
Since the work of McCord and Fridovich in 1969 on superoxide dismutasc.
considerable interest has been focused on the relation between free radicals
[superoxide (O2- and hydroxyl (OH—) anions and other reactive oxygenated species
(RUSH and aging of the skin. The origin of free radicals may be endogenous
(activation of arachidonic acid metabolism. activation of phagocytosis or
accumulation of reduced metabolites) or exogenous (radiation, UV from sunlight, air
pollution, tobacco smoke, pesticides and more).
All cells have varying degrees of a chemical and enzymatic anti-free radical arsenal.
This enables them to exert a natural protection against these highly reactive molecules
and to optimally control their deleterious effects. Cellular responses may differ,
however, depending on the extent of the oxidative stress. Low quantities of ROS
stimulate cell proliferation and the over expression of antioxidant enzymes that can
adapt and react to the stress. When produced in excessive quantities, on the other
hand, ROS attack a series of biological substrates. These defense systems are often
overwhelmed and cannot handle an overpowering radical flux. This saturation
phenomenon is accentuated with age. In this case, ROS cause cell damage that is
often irreversible and can even lead to cell death (McCord ct al.. I996). The major
effects of this uncontrolled oxidative stress are intense, targeted and irreversible:
oxidation of proteins and enzyme inactivation, DNA chain breaks and lipid
peroxidation.
Example 1
Swedish cranberry fruit (Vaccinium vitis idea) extract is more effective than
European cranberry fruit (Vaccinium oxycoccus) extract at protecting human
keratinocytes from oxidative stress.
Active oxygen species and other free radicals are presumed to participate in actinic
aging. In order to determine the protective activities of certain substances. cell
viability tests were conducted. Cultures of human keratinocytes were artificially
subjected to a stress by the hypoxanthine-xanthine oxidase system. The free radicals
formed during this stress are responsible for increased cell death. The anti—oxidant
activity of the product tested was determined by measuring cell viability.
Human keratinocytes were inoculated in 12-well plates at 2 ml of cell suspension per
well. Cell cultures were incubated for 2 hours in the presence or absence of extracts at
% and 2% and were subjected to a chemical aggression with a solution of
hypoxanthine (160 pg/ml) — xanthine oxidase (l0 mU/ml). The protective effects of
extracts towards chemically-induced free radicals were assessed by the
spectrophotometric measurement of cell viability carried out with the M'l"l‘ method
(3~(4.5-dimethyl thiazolyl)-2.5 diphenyl tetrazolium bromide) at 540 nm.
The results are expressed as percentage of efficacy.
A - B
% efficacy = x 100
With:
A untreated control — A treated control
A = Control toxicity =
A untreated control
A untreated product —- A treated product
B = Product toxicity = e——
A untreated product
Tests were run in triplicate. The results are shown in table 1.
EFFICACY (%)
TABLE I % Concentration 2% Concentration
T Swedish Cranberry fruit 95% 100%
European Cranberry fruit 27% 34%
Lg _
Swedish cranberry fruit extracts (Vacc1'm‘zm1 vitis idea) are clearly more effective than
European cranberry fruit extracts (Vaccmzzmiz oxycoccus) at protecting against
oxidative stress.
Example 2
Demonstration of synergy of lingonberry (Swedish cranberry) leaf & fruit
extracts on photoprotection of human kcratinocytes.
The aim of this study was to determine the ph0to—protective activity of lingonberry
leaf & fruit extract compared to the lingonberry leaf extract and to the lingonberry
fruit extract against UVB irradiation of human keratinocytes.
Keratinocytes were grown in KSFM medium (lnvitrogen) inoculated at a density of
70.000 cells/well in 24-well plates. Irradiation was with a « Biosun>> UV iamp
(Vilbert-Lourmat, France). UVB intensities were 0.6J/cm2, respectively, in the
presence of:
— lingonberry leaf extract at 0.50% & l%
- lingonberry fruit extract at 0.50% 8; 1%
- lingonberry leaf& fruit extract at 0.50%. & l%
After irradiation, the cells were kept at 37°C for 6 hours in a humid atmosphere
containing 5% C02. The photo—protective effect of each product was estimated by
measuring keratinocyte viability after staining with M.T.T. The results are expressed
as percentage ofcell protection.
A - B
Cell protecti0n/ control (%) = x 100
Abs non-irradiated control — Abs irradiated control
with A: control toxicity =
Abs non—irradiated control
Abs non-irradiated product - Abs irradiated product
B: product toxicity =
Abs non—irradiated product
Abs: absorbance. All experiments were run in triplicate.
The results are shown in table 2:
Table 2: Photo-protective effect of LINGONBERRIES (Fruit, Leaves, Mix
”Leaves & Fruit”) Extracts after UV aggression
Dosage
Mean results
Fruit + Leaves
Mean
results
Fruit
( MP1)
Mean (MFI +
results MLI) /
Leaves 2
(ML 1)
,5% l0 70 40 53
,0053 "Synergy
% 23 100
l .5 66 0.0041
Synergy
In all further experiments only the effects ofthe combined extracts on cellular activity
is shown although both individual extracts are effective.
Example 3
Effect of lingonberry (Swedish cranberry) leaf & fruit extract as a strong anti-
radical agent.
The skin is the front line barrier of defense against environmental pollutants including
chemical pollution (industrial pollution, exhaust gases) or solar radiation.
Environmental pollutant factors trigger a response from the defense system ofthe skin
as a result of their oxidizing properties. They induce an oxidative stress and an
imbalance in the antioxidant system of the skin (Afaq et al., 2001) due to the
formation of free radicals. The body is naturally protected from these free radicals by
chemical or enzymatic detoxification systems that may become overloaded. lt then
mobilizes free radical traps that can stop these reactions. Free radicals produced by
various types of diverse aggressions (stress, pollution, tobacco), are now considered
as agents responsible for premature aging by causing, among other things.
deterioration of tissues, damage to DNA and to the immune system.
The aim of this study was to determine the chelating capacity of Iingonberry (Swedish
cranberry) leaf & fruit extract towards metal ions such as iron. The principle is based
on quantifying free metal with a spectrophotometric assay. The assay ofthe chelation
capacity of iron (iron solution at 10 mg/l) by Iingonberry (Swedish cranberry) leat‘&
fruit extract was conducted with a colorimetric kit (SIGMA, method No. 565). The
reagent ferrozine, a sulfonated derivative of diphenyltriazine, forms a water-soluble
magenta complex with iron not complexed by Iingonberry (Swedish cranberry) leaf&
fruit extract. Lingonberry (Swedish cranberry) leaf & Fruit extract was tested at
0.50%. l% and 2%.
The results are shown in table 3:
,_________
Table 3: Concentration Chelating activity (%)
Lingonberry (Swedish cranberry) leaf& fruit extract at 1% presents a strong chelating
activity towards iron.
Example 4
Effect of Iingonberry (Swedish cranberry) leaf & fruit extract on keratinocytes
vitality after UV irradiation.
UVB radiation is responsible for phenomena of sunburn and immuno—suppression. lt
also causes a number of skin disorders, the most important of which are skin cancers.
In addition, it damages DNA. UVA is the major component of the UV portion of the
solar spectrum and is involved in skin aging, particularly slackening of the skin. It is
The indirect
also involved in the suppression of certain immunological functions.
effects of UV/\ arise from photosensitization reactions following the absorption of
.50% 27
% 48.
S’ T~i2"°/0 31 T”~~
_.‘ ____L.__.._}_,, , .-,--,- _
UVA by different cell ehromophores. UV radiation is also responsible for the
formation of particular chemical species called reactive oxygen species (ROS) that
have the capacity to create considerable damage directly at the level of the cell‘ such
as the oxidation of proteins (Sander et al.. 2002) that lose their functionality. lipids or
nucleic acids. Fortunately cells have defense systems that are effective against
oxidative stress and combat a variety ofday to day aggressions.
The aim of this study was to determine the photo-protective activity of lingonberry
(Swedish cranberry) leaf & fruit extract against UVB irradiation of human
keratinocytes. Free radicals induced by UV radiation are responsible for an increase in
cell death. The protective activity of the product studied can thus be determined by the
spectrometric measurement of cell viability after staining with M.T.T. Keratinocytes
were grown in KSFM medium (lnvitrogen) inoculated at a density of 50,000
cells/well in 12-well plates. Irradiation was with a « Biosun » UV lamp (Vilbert-
Lourmat. France). UVB intensities were 0.l3J/cmz, respectively, in the presence of
lingonberry (Swedish cranberry) leaf & fruit extract at 0.10%, 0.25%, 0.50%. and
1% .After irradiation, the cells were kept at 37°C for 24 hours in a humid atmosphere
containing 5% C02. The photo-protective effect each product was estimated by
measuring keratinocyte viability after staining with M.T.T.
The results are expressed as percentage of cell protection.
A-B
———-~x too
Cell protection/ control (%) =
A
Abs non-irradiated control - Abs irradiated control
with A: control toxicity =
Abs non-irradiated control
Abs non-irradiated product - Abs irradiated product
B: product toxicity =
Abs non-irradiated product
All experiments were run in triplicate. The results are shown in table 4A
|_..\
DJ
Table 4: Concentration Cell protection / control (%)
0.10% + 31
.25% —_i— M + 47
0.50% + 63
1% + 75 ”
Lingonberry (Swedish cranberry) leaf & fruit extract shows a clear protection olicells
against UVB-induced free radicals.
Example 5
Effect of lingonberry (Swedish cranberry) leaf & fruit extract on keratinocytes
DNA after UV irradiation.
The DNA molecule is a double helix composed ofa succession of deoxyribose rings
(sugar) and phosphate groups. A purine or pyrimidine base is attached to each sugar
residue. The basic unit of this structure is called a nucleotide, composed of a sugar, a
phosphate group and one of the purine or pyrimidine bases. The purines are adenine
(A) and guanine (G); the pyrimidines are cytosine (C) and thymine (T). Their precise
succession determines what we call the DNA sequence. Deoxyribonucleic acid
(DNA) is the support for genetic information, the "hard disk" of the cell. It is
contained in the nucleus ofall cells of the organism and is responsible for storing and
transmitting genetic information (Robert. i995). The integrity ofthe DNA molecule is
under permanent threat. The molecule is in fact deteriorated by endogenous free
radicals. diverse chemicals and above all by UV A, B and C radiation. Ionizing
radiation results in a modification of nucleotide bases with the formation of
pyrimidine dimers and strand lesions. These lesions prevent the correct operation of
cells and cause genetic mutations which are often carcinogenic. There are DNA repair
mechanisms to combat these aggressions. The most effective mechanism is excision
repair. This process is carried out by a multi~enzyme system that recognizes
pyrimidine dimers, cuts the damaged strand of DNA, eliminates it and stimulates the
synthesis ofa new DNA strand. The new strand is identical to the fragment eliminated
and is complementary to the intact opposite strand. In some cases. the lesion is not
recognized or the repair mechanisms are incomplete. These defects result in a
considerable risk of genetic mutation. This is why it is important to protect DNA
strands by the use of antioxidants that can attenuate the risks of lesions.
In order to determine the protective effect of lingonberry (Swedish cranberry) leaf &
fruit extract against UVB radiation, 21 DNA fragmentation test was used. UVB
radiation causes chain breaks in DNA strands. This fragmentation can be visualized
after extraction and electrophoresis of DNA. Our active ingredient must thus be
capable of protecting DNA from breaks caused by solar radiation. Human
keratinocytes were incubated at 37°C for 1 hour before UVB irradiation in an
incubator containing 5% C02 in the presence or absence of lingonberry (Swedish
cranberry) leaf & fruit extract at 1% (D0, T0h). lrradiations were with a << Biosun »
UV lamp (Vilbert-Lourmat, France) with a UVB intensity of I80 m.l/cmz in the
presence or absence of the product. The cells were then returned to the incubator
(37°C. 5% CO2) (D0, Tl h). After 24 hours of incubation, DNA was extracted from
the cells. DNA strand breaks were visualized after electrophoresis on agarose gels.
and analyzed using the Bl0—PROFlL'i"7' system (Vilbcrt—Lourmat, France) (DI). The
results are in table 5.
DNA protection
TABLE 5 / Irradiated control (‘’/o) l
~-l
Irradiated control ‘ 0
UVB + '1
% CONCENTR ATE
Lingonberry (Swedish cranberry) leaf & fruit extract at 1% protects keratinocyte
DNA from UVB—induced damage.
Example 6
Effect of lingonberry (Swedish cranberry) leaf & fruit extract on epidermal
differen tiation.
The epidermis is a stratified epithelium composed of cells whose morphology is
specific to each layer. During their migration towards the surface. kcratinocytes
undergo biochemical and structural modifications that progressively transform them
into keratinized cells: corneocytes that are eliminated by desquamation. In order to
maintain a constant thickness, the epidermis is renewed by cell divisions of stem cells,
followed by the differentiation of keratinocytes into corneocytes. The terminal
differentiation of the corneocyte requires the formation of an intracorneocyte fibrous
matrix, the production of intercellular lipids and the appearance ofa keratin envelope.
The fibrous matrix that replaces the cytoplasm and nucleus of the keratinocyte is
formed from profilaggrin contained in keratohyalin grains of the stratum granulosum.
Profilaggrin is converted to filaggrin by a cascade of steps including
dephosphorylation and proteolysis. Filaggrin enables the aggregation of cytokeratin
filaments and is then degraded totally to form NMF, hygroscopic substances with a
high capacity to bind water. The formation of the keratin envelope starts in the
Malpighian body from precursor proteins (involucrin, keratolinin, loricrin) and with
the participation of calcium and a membrane enzyme, transglutaminase that creates
covalent bonds between these proteins. lnvolucrin is among the most important
proteins since it is the protein skeleton of the plasma membrane of corneocytes. The
keratin envelope makes corncocytes rigid and is responsible for the high mechanical
resistance of the stratum corneum. Cadherins play an essential role not only in
intercellular adherence. but also in the control of cell morphogenesis and
differentiation. Cadherin-E participates in the regulation of proliferation and
differentiation (Kee et al., 2001). It is expressed by Langerhans cells and
keratinocytes, and enables the adhesion of these two cell types. It is localized in all
cell layers ofthe epidermis, with predominance in differentiated layers (Serres, I997).
The aim of this study was to determine the effect of lingonberry (Swedish cranberry)
leaf & fruit extract on the expression of messenger RNAs coding for
transglutaminase—l, a marker of keratinocyte differentiation. The study was conducted
on cultures of human keratinoeytes. Human keratinocytes were grown for 48 hours at
37°C in an incubator in an atmosphere of 5% CO2 in the presence of lingonberry
(Swedish cranberry) |eaf& fruit extract at 0.50%. At the end of incubation. the cells
were recovered and total RNA was extracted. The RNA was subjected to reverse
transcriptase and the complementary DNA obtained was analyzed with PCR, using
oligonucleotidcs complementary to a sequence coding for the genes of the proteins
studied ttransglutaminase and Cadherin E). B-actin mRNA. the internal standard. was
also analyzed in each experimental condition. The intensity of amplicon bands on
agarose gels was quantified by image analysis (BlO—PROFlL® system. BIO-ID
software. VILBERT-LOURMAT, France). The results are expressed as the ratio of
intensity of the band of the gene analyzed over that of the internal standard (B—actin).
The results are shown in table 6 & 7.
The results are expressed as percentage of expression oftransglutaminase-1 mRNA.
TABLE 6 mRNA rate (°/o)
Control 100
0.50% CONCENTRATE 1 18
Tested at 0.50%, the extract regulates the keratinocytes differentiation by increasing
the expression oftransglutaminase-l and cadherin—E.
The results are expressed as percentage of expression of cadhcrin-E mRNA.
mRNA rate (%)
Control 100
TABLE 7
.50% CSNCENTRATE
Lingonberry (Swedish cranberry) leaf & fruit extract at 0.50% supports the expression
ofcadherin-E (+20%), marker ofthe keratinocyte differentiation.
Example 7
Effect of lingonberry (Swedish cranberry) leaf & fruit extract on collagenase
(MMP-1) activity.
Collagen is the fibrous protein most abundant of conjunctive fabric, responsible for
cutaneous lonicity. The activity anti-collagenase limits the degradation of collagen
fibers. The aim of this study was to assess the anti—col|agenase activity of lingonberry
(Swedish cranberry) leaf& fruit extract. One unit of collagenase is able to hydrolyze
lumol of FALGPA (furylacryloyl-Leu-Gly—Pro—Ala; Sigma, F5l35) per minute at
°C, pH 7.5 with calcium ion. This hydrolysis reaction involves a decrease of the
absorbance at 324nm. If a product has an anti-collagenase activity, it will inhibit the
reaction on the FALGPA substrate and the absorbance will not decrease.
The result is expressed as percentage of anti-collagenase activity.
AA(blank) — AA(sample)
% activity = x I00
AA(blank)
/\A(To) — AA(TlOmin)
With 1 AA = ————z———
The results are shown in table 8.
TABLE 8 Anticollagenase activity (%)
1% C ONCENTRATE 3l
2% CONCENTRATE 47
% CONCFNTRATE 75
Tested at 2%, Lingonberry (Swedish cranberry) leaf & fruit extract limits the
collagenase activity by 47%.
Example 8
Anti-wrinkle effect of lingonberry (Swedish cranberry) leaf & fruit extract.
The aim ofthis study was to quantify in vivo the anti-wrinkle efficacy ofthe products
N°253 (placebo) and 694 (placebo + 3% of Lingonberry (Swedish cranberry) leaf &
fruit extract) on the crow's feet. The study was conducted double blind on 24
volunteers presenting wrinkles on the crow's feet. The area of application for the
products is randomized (left crow’s feet/right crow's feet). Replicas of the two crow's
feet were made before and after 28 days oftwice daily application.
The anti-wrinkle effect of the products N°253 and 694 were analyzed by observing
replicas with the help of a profilometer equipped with an image analy7er. Silicone
polymer replicas were made before and after application ofthe product and examined
by S.l.A. (silicone image analysis). Grazing light at an incidence of35° casts shadows
on the surface of the impression that are then observed with a CCD camera connected
to a computer. The field examined was 1 cm2. The gray level analysis of the resulting
computer image provides the following parameters using QUANTIRIDES 99®
(MONADERM, Monaco) software:
- The number of wrinkles
- The total wrinkled surface
- The total length of wrinkles
The results were calculated as a percentage using the mean of variation of wrinkle
parameters observed under the effect of the product compared to D0:
Pdt D28 — Pdt DO
Variation / D0 (%) =
With:
Pdtooz Result before application of the product
Pdtmg: Result after 28 days of product application
The results are shown in table 9:
Table 9: Anti-wrinkle effect of the products 253 and 694
° Number of wrinkles
Product 253 Product 694
D0 D28 D0 D28
M63“ 197 192 211 184
SEM 1 1 9 12 13
A / D0 _1 1%
W’) 1%
P M868 0.01
° Total wrinkled surface
Product 253 Product 094
D0 D28 D0 D28
M
63" 24.43 25.22 24.71 21.07
SEM 1.84 1.67 1 .57 _A_m17_._9%2 W_\_
A / D0
(0/°’ 9% 44%
P 0.3024 0.0022
0 Total length
Product 253 Product 694
D0 D28 D0 D28
M63“ 129.83 132.44 135.62 114.16
SEM 8.79 _ 7.78 8.22 8.36
A / D0
W") 7% .14%
P 6 0.3492 0.0015
After 28 days of twice daily application. the product N°253 (placebo) shows no anti-
wrinkle effect compared to D0.
After 28 days of twice daily application. the product N°694 (placebo + 3% of
Lingonberry (Swedish cranberry) leaf & fruit extract) decreases significantly the
different parameters characteristic of the skin aspect:
- Number of wrinkles by l 1% (P=0.0l42)
— Total wrinkled surface by 14% (P=0.0022)
- Total length ofwrinkles by 14% (P400015)
Example 9
Effect of lingonberry (Swedish cranberry) leaf & fruit extract on skin elasticity.
The aim of this study was to quantify in vivo the effect of the products N°253
(placebo) and 694 (placebo + 3% of Lingonberry (Swedish cranberry) leaf & fruit
extract) on skin elasticity. The study was conducted double blind on the face of 24
volunteers. The area of application for the products is randomized (left face/right
face). Measurements were made on the check before and after 28 days of twice—daily
treatment using an SEM 575 Cutometer® (Courage & Khazaka, Germany).
The skin is sucked into the orifice of a probe by a constant vacuum for a constant
period. Several successive suctions may be carried out. The depth of penetration of
the skin in the probe is measured with two optical prisms placed at the opening ofthe
probe (no friction or mechanical effect). Using the curves obtained, it is possible to
calculate a number of parameters characteristic of the mechanical properties of the
skin.
The following is a typical curve obtained during a measurement involving five
I 1 I [ l
I I I | I
35 40
successive 5 second suctions.
Deformation
U
L
L. 40 '
(mm)
[..,.a.__c_.aa::‘ _
. f
Uv
Ue
Ua
X k,
Ue: Instantaneous deformation (elastic component)
Uv: Delayed deformation (viscous component)
Uf: Uv + Ue = extensibility or total elongation
U’f: Final extensibility
Ur: Immediate retraction
x: Residual retraction
temps 4(8)
x : Residual deformation after 5 cycles
Ua: Total retraction.
Among all the parameters calculated from the resulting curves, the following were
selected to quantify changes in biomechanical properties resulting from the product
- Ur/Ue = R5 If R5 increases, skin elasticity increases.
— Ua/Uf = R2
lf R2 increases, skin elasticity increases.
The results were calculated as percentage using the means of variations of skin
elasticity parameters observed under the effect ofthe product compared to DO:
Pdt D28 — Pdt D0
Variation / D0 (%) = —» x 100
Pdt D0
With:
Pdtpoi Result before application of the product
Pdtmg: Result after 28 days of product application
The results are shown in table 10:
Table 10: Effect ofthe products 253 and 694 on skin elasticity
Parameter R2
Product 253 Product 694
DO 028’ D0 D28
M63“ 0.660 0.714 0.534 0.710 oooo Ht‘
MSEM 0.026 0.029 0.024 0023 J
AIDO
(%) 11% 15% 0
P 0.0550 _g0_12_1__
Parameter R5
Product 253 Product 694
[)0 D28 Do i D28
M93“ 0.572 0.597 0.575 0.639
'5” 0.031 0.029 9932 0.026
A I DO
(°/°) 10% 17%
P 0.2411 0.0323
After 28 days ofapplication, and in the conditions ofthis study:
- The product N°253 (placebo) tends to increase the R2 and the R5 parameters, which
represent the elasticity of the skin (+11%; +10%). This increase is non significant
(P>0.05).
- The product N°694 (placebo + 3% of Lingonberry (Swedish cranberry) leaf& fruit
extract) increases significantly the R2 and R5 parameters which represent the
elasticity of the skin:
- Increase ofthe R2 parameter by l5% (P=0.0l2l)
- Increase of the R5 parameter by 17% (P=0.0323).
Example 10
In this example lingonberry (Swedish cranberry) extract were included in the
inventive compositions.
The formulation below describes an oil in water cream incorporating the inventive
composition which is suitable for the methods and uses according to the present
invention. The percentages indicated are by weight of the composition unless stated
otherwise.
W’[°/0
IIYDROGENATED POLYISOBUTFNE 4.5
CYCLOPENTASILOXANE 4.5
DIMETHICONE 7--5
Example 11
GLYCERYL STEARATE 2
C ETYI. ALCOHOL 2
PEG-40 STEARATE 1,25
SODIUM ACRYLATE/ACRYLOYLDIMETHYL l
TAURATE CUPOLYMER
TOCOPHERYL ACETATE 0.5
PRESERVATIVES QS
PERFI IMF, QS
LINGONBERRY VITAL CONCENTRATE V 3
WATER to 100
The formulation below describes a foundation incorporating the inventive
composition which is suitable for the methods and cases according to the present
invention. The percentages indicated are by weight of the composition unless stated
otherwise.
Wt°/o
CYCLOPENTASILOXANE
PIGMENTS
POLYGLYCERYL-4 ISOSTEARATE
ISODODECANE
-¥>~UI\O
BUTYLENE GLYCOL
BlS—PEG/PPG-l4/l4 DIMETHICONE
HYDROGENATED POLYISOBUTENE
BEESWAX
MAGNESIUM SULPHATE
PRESERVATIVES
””
LINGON BERRY VITAL CONCENTRATE
K’.-
WATER
to 1
Example 12
The formulation below describes a body scent incorporating the inventive
composition which is suitable for the methods and cases according to the present
invention. The percentages indicated are by weight of the composition unless stated
otherwise.
Wt‘)/0
DEN ATURED ALCOHOL
PROPYLENE GLYCOL
GLYCERINE
BENZOPHENONE—2
PERFUME
SOLUBILISER
L») l\) O\ Q U3 U1 U1
LINGONBERRY VITAL CONCENTRATE
WATER to 100
All the above topical compositions provide an effective cosmetic treatment to improve
the appearance of wrinkled, aged, photo—clamaged, and/or irritated skin, when applied
to skin that has deteriorated through the aging or photo-aging or when applied to
youthful skin to help prevent or delay such deleriorative changes. All the
compositions may be processed in conventional manner.
The words “comprises/comprising" and the words “having/including“ when used
herein with reference to the present invention are used to specify the presence of
stated features, integers, steps or components but does not preclude the presence or
addition of one or more other features, integers, steps, components or groups thereof.
l‘ .)
‘II
lt is appreciated that certain features of the invention, which are, for clarity. described
in the context of separate embodiments. may also be provided in combination in a
single embodiment. Conversely, various features ofthe invention which are, for
brevity, described in the context ofa single embodiment, may also be provided
separately or in any suitable sub-combination.
Claims (5)
1. Use of a therapeutically effective amount of an aqueous extract of a combination of lingonberry (Vaccinium vitis idea) fruit and leaf extract and/or derivatives thereof, in the manufacture of a cosmetic composition for treating skin conditions.
2. Use according to claim 1 wherein about 50% by weight of the lingonberry (Vaccinium vitis idea) extract, and/or derivatives thereof, is present as the leaf extract and the other 50% as the fruit extract.
3. Use according to claim I or 2 wherein the composition comprises between 0,0001% to 50% by weight of lingonberry (Vaccinium vitis idea) extract, preferably between 0.01% to 10% by weight of lingonberry (Vaccinium vitis idea) extract, more preferably between 0.1% to 5% by weight of lingonberry (Vaccinium vitis idea) extract.
4. A topical composition comprising: (a) a therapeutically effective amount of an aqueous extract of a combination of lingonberry (Vaccinium vilis idea) fruit and leaf extract together with (b) a dermatologically acceptable carrier.
5. A topical composition substantially as hereinbefore described and/or with reference to the examples. TOMKINS & C().
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IEIRELAND17/06/20052005/0411 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IES84572Y1 true IES84572Y1 (en) | 2007-05-02 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11752168B2 (en) | Methods of using cosmetic compositions comprising exopolysaccharides derived from microbial mats | |
| KR101746843B1 (en) | Use of a polyphenol-rich plant extract as antioxidant in combination with a hydrating or humectant agent | |
| KR101932766B1 (en) | Dendrobium chrysotoxum extract and its cosmetic use as an anti-aging agent | |
| US10532023B2 (en) | Camellia japonica extract and cosmetic compositions containing same | |
| Murad et al. | The effect of an oral supplement containing glucosamine, amino acids, minerals, and antioxidants on cutaneous aging: a preliminary study | |
| WO1999024009A1 (en) | Uses of d-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells | |
| JP2025517588A (en) | Composition containing Matsutake extract having anti-aging effect and use thereof | |
| FR2897266A1 (en) | COSMETIC USE OF A PICHIA ANOMALA EXTRACT | |
| US20050208160A1 (en) | Activities of an active principle obtained from powdered alfalfa seeds (medicago sativa) , active principle used and process of obtaining the same | |
| IE20050411A1 (en) | Cosmetic compositions containing lingonberry (vaccinium vitis idea) extracts | |
| KR100874115B1 (en) | Cosmetic composition containing thyme extract as an active ingredient | |
| US9084744B1 (en) | Use of Tiliacora triandra in cosmetics and compositions thereof | |
| WO2011113785A2 (en) | A cosmetic composition for rejuvenating skin appearance | |
| EP2722075B1 (en) | Prevention of conditions arising from an impaired skin barrier function | |
| US20240091294A1 (en) | Extract of Top Growth of Holy Basil, and Cosmetic or Dermatological Compositions Containing Same | |
| IES84572Y1 (en) | Cosmetic compositions containing lingonberry (vaccinium vitis idea) extracts | |
| KR20070021585A (en) | Skin external preparation containing dolna extract as main active ingredient | |
| KR20180124443A (en) | Cosmetic composition for enhancing skin barrier containing extract of Tremella fuciformis fruiting body | |
| JPH11171722A (en) | Preparation for external use for skin | |
| KR102469550B1 (en) | Cosmetic composition with uv protection, whitening and wrinkle improvement effects | |
| EP1009378A1 (en) | Use of the rhoeo discolor plant extracts in cosmetics and pharmaceutics, in particular in dermatology | |
| AU2009238172B2 (en) | Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof | |
| US20250152499A1 (en) | Compositions and methods for supporting skin barrier homeostasis | |
| KR20250086334A (en) | Cosmetic composition for the improvement of melasma, freckles, and whitening and the manufacturing method thereof | |
| HK40072119A (en) | Extract of moringa peregrina seed cake, method for obtaining same and use thereof in cosmetic or nutricosmetic compositions |